NEI Research News

Research from the University of Utah explains why people with genetic variants may develop age-related macular degeneration (AMD) and identifies a potential therapeutic pathway for slowing disease progression.

Tiarnan Keenan, NEI Division of Epidemiology and Clinical Applications, and colleagues found that people with age-related macular degeneration (AMD) can successfully use the Notal Home OCT device to monitor their disease.

Researchers at UAB have discovered a small molecule inhibitor that dampens the potent drivers of uveal melanoma.

When looking at a complex landscape, the eye needs to focus in on important details without losing the big picture. Now, a new study by Salk scientists shows how inhibitory neurons play a critical role in this process.z

NEI and European researchers hosted international investigators on June 18, 2021, to present and discuss recent advances in age-related macular degeneration (AMD) and its relationship to the microbiome.

Scientists studied the brain activity of school-aged children during development and found that regions that activated upon seeing limbs (hands, legs, etc.) subsequently activated upon seeing faces or words when the children grew older.

Researchers at the National Eye Institute (NEI) have determined how certain short protein fragments, called peptides, can protect neuronal cells found in the light-sensing retina layer at the back of the eye.

A team led by researchers at Washington University School of Medicine in St. Louis has identified, in mice, specific cells and proteins that control the sneeze reflex.

A new study by researchers at MIT’s Picower Institute for Learning and Memory substantially advances understanding of how a mammalian brain enables “visual recognition memory.”

Consuming large amounts of daily caffeine may increase the risk of glaucoma more than three-fold for those with a genetic predisposition to higher eye pressure according to an international, multi-center study.